News

News

Yankees’ Star Aaron Judge Reveals Surprising Hope as Opening Day Approaches

by

New York – As MLB teams warm up for the impending rush of Opening Day, New York Yankees’ slugger Aaron Judge has expressed a surprisingly understated wish for the 2023 season: personal health and a championship for his team. The two-time American League MVP, coming off an exceptional season where he broke the American League home run record, shared these thoughts in a recent team press conference. Judge’s focus on health does not come devoid of context. His career, although illustriously laden with accolades like the Rookie of the Year title in 2017 and three … Read more

Deadline Approaches for BioAge Labs Investors to Join Securities Fraud Lawsuit Following Failed Clinical Trial

by

SAN DIEGO — Robbins Geller Rudman & Dowd LLP, a prominent law firm, has issued an announcement regarding a class action lawsuit against BioAge Labs, Inc., urging investors to come forward if they were affected by the company’s recent IPO issues. Shareholders who acquired stock in BioAge Labs (NASDAQ: BIOA) during its initial public offering on September 26, 2024, or based on the related registration statement, are invited to seek a lead plaintiff position in the lawsuit by the impending deadline of March 10, 2025. The lawsuit, officially known as Soto v. BioAge Labs, Inc., … Read more

Grand Jury Indicts Suspect Charged with the Murder of Palm Beach County Sheriff’s Deputy

by

West Palm Beach, FL – A man has been indicted on a murder charge in the shooting death of a deputy from the Palm Beach County Sheriff’s Office, an event that has shaken the local law enforcement community. The indicted suspect is accused of fatally shooting the deputy while he attempted to serve a warrant. The grand jury’s decision to indict the man was confirmed recently, punctuating a tragic incident that has led to an outpouring of grief among officials and residents alike. The deputy had been part of a task force involved in a … Read more

Bleichmar Fonti & Auld LLP Files Lawsuit Against BioAge Labs Over Alleged IPO Misrepresentations, Urges Investors to Join Legal Action

by

NEW YORK — Legal actions have commenced against BioAge Labs, Inc., a clinical-stage biopharmaceutical company known for its advanced therapies aimed at metabolic diseases like obesity. A lawsuit filed in the U.S. District Court for the Northern District of California accuses BioAge and some of its top executives of potential breaches of federal securities laws. The securities law firm Bleichmar Fonti & Auld LLP, leading the litigations, announced these proceedings detailing that the lawsuit encapsulates claims under Sections 11 and 15 of the Securities Act of 1933. The complaint specifically represents investors who acquired shares … Read more